Since its inception in 1920, The Union has had a focus on tuberculosis (TB) and innovating TB care.
We have now set out our 2022-2027 vision, objectives and strategy for ending TB. This can only be achieved collectively, with our members, partners and TB community – everyone has a role to play.
Together, we can bring an end to TB.
Our work in TB
The Union works towards the global elimination of TB. We support high-quality, accessible prevention and care for people with and at risk of TB, to expand the evidence base for TB care and prevention and implement new knowledge into policy and practice.
Project Axshya
In collaboration with local partners and over 15,000 community volunteers, The Union provided innovative tuberculosis (TB) interventions designed to serve traditionally hard-to-reach and at-risk populations in India.
Specific TB priority areas
Read more about how The Union is working to fight key areas of TB:
Child & Adolescent Tuberculosis
The Union works to develop, test, implement and scale up routine screening of child contacts of people with TB. We run observational studies and advocate to ensure children and adolescents are included in clinical trials that target diagnostics, vaccines and treatment of TB disease and infection.
TB-HIV, TB-Diabetes and other co-morbidities
The Union develops, tests, implements and scales up models of care for co-morbid conditions that increase the risk of developing TB, that are prevalent in high TB burden settings, or that adversely affect TB treatment outcomes.
The Zoonotic TB Sub-section was instrumental in the creation of the first-ever Roadmap for Zoonotic TB, a policy document that addressed the major health and economic impacts of the disease, created in collaboration with the World Health Organization.
Members work together to influence global policy and practice, ensuring their work has a greater global impact.
Understand the issues with our factsheets
Tuberculosis Union news
Urgent call for continuity of TB services during the COVID-19 pandemic in China
Our survey revealed that COVID-19 led to a significant disruption in TB diagnosis and care at major hospitals throughout China. We urgently call for additional investment directed toward improving the availability of diagnostics and therapeutics such that equitable access to care can be maintained during times of crisis.
Preventing TB in people with diabetes: where are we now and where are we going?
To mark World Diabetes Day, 14 November, Professor Anthony Harries, Senior Adviser at The Union writes about the changing landscape and…
The Union’s Director of TB, Dr Grania Brigden makes intervention at Rome 5
The Union’s Director of TB, Dr Grania Brigden makes intervention at Rome 5
Bedaquiline: Rolling out the first new TB drug since 1960
A special thematic issue of The Union's International Journal of Tuberculosis and Lung Disease explores increasing access to this vital treatment for multidrug-resistant TB.
Message from the Executive Director
Colleagues, friends, members,
This is a poignant moment for me. This is the final time that I speak to you as the…
The Union shares mid-term report on impact of COVID-19 on people with TB and HIV/AIDS in Africa
The Union’s Centre for Operational Research has made publicly available the mid-term report of the impact of COVID-19 on tuberculosis (…
TB Publications
Until recently, the focus has been on finding and treating people with TB. But now bold targets for TB prevention have been outlined in the recent UN High-Level Meeting on TB. The Union develops, tests, implements and scales up models of care to increase the uptake and completion of TB preventive treatments in key high risk groups including children under 5 and people living with HIV.
'Prevent Tuberculosis: Management of TB Infection' is a free course which improves knowledge of all aspects of the management of TB infection including the diagnosis and treatment of tuberculosis with the specific aim of increasing country-level implementation of TB prevention among i) household contact of people affected by TB, especially those under five years of age, ii) persons with risk factors to develop TB, and iii) people living with HIV in care.